Why this might matter to you
No gene gets more wellness marketing per unit of biology than MTHFR. Consider this your guide, grounded in fact, to the nuance behind whatever else you may read.
MTHFR has two variants the supplement market likes to sell as a matched set. C677T is the famous one. A1298C is the other half of the pitch, the variant invoked to explain whatever C677T did not already cover. Its actual biology is much less exciting than the marketing suggests. MTHFR is the gene that helps your body turn the folate (vitamin B9) you eat into the active form your cells use. A1298C is a second, common change in that same gene, at a different spot from C677T. You carry zero, one, or two copies. On its own, it does very little that the published evidence can pin down. Where it earns attention is in combination with C677T, and even there the strongest single study lands short of statistical significance. That is a normal piece of human variation, not a diagnosis, and certainly not anything to fixate on. It's simply something to know about your own DNA to have more insight into how your body functions.
What it does and doesn't change
The established part is small and specific. A1298C sits in a different region of the MTHFR gene than C677T, and on its own it is tied much less tightly to the homocysteine rise that C677T is known for. The scenario to focus on is compound heterozygosity: one copy of A1298C together with one copy of C677T. What A1298C does not do is act as a second independent defect that doubles a methylation problem, or tell you that you need a particular supplement. The one published figure that looks at the compound pattern and a disease outcome did not reach statistical significance, which is a detail the protocols built on this variant tend to leave out.
What the genotype is
MTHFR A1298C is read at a single position, rs1801131, on chromosome 1. A raw DNA file reports two letters at this spot. The reference genotype (T,T) carries no A1298C change and shows standard enzyme activity at this position. One copy (T,G) is the heterozygous form. Two copies (G,G), the homozygous form sometimes written 1298CC, carry the variant on both chromosomes. The name "A1298C" follows a standard DNA-naming convention, pointing to the change at nucleotide position 1298.
It is a common variant, and the numbers make this point unambiguous. In gnomAD reference data, the A1298C allele appears at roughly 31 percent globally and roughly 31 percent in the non-Finnish European population, and that dataset records more than 70,000 homozygous individuals. A genotype shared by tens of thousands of catalogued people is variation, not defect.
What the literature reports
A1298C and C677T are distinct changes in the same gene, at different positions. The enzyme they encode converts 5,10-methyleneTHF into 5-methylTHF, the active folate form the body uses to recycle homocysteine back to methionine, which is why this pathway is studied alongside folate and B vitamin status PMID 20814827. A1298C's documented effect on that pathway, taken alone, is modest, and it is tied to homocysteine far less strongly than C677T.
The most cited A1298C result comes from a case-control study of neural tube defects. It reported that combined heterozygosity, one A1298C allele together with one C677T allele, was associated with neural tube defect risk at an odds ratio of 2.04, seen in 28 percent of the 86 patients versus 20 percent of the 403 controls PMID 9545395. Its 95 percent confidence interval ran from 0.9 to 4.7. That interval crosses 1.0, which means the data are consistent with no effect at all, and the result did not reach conventional statistical significance. A single study with a wide, boundary-crossing interval is a start, but no conclusions can be derived at this stage regardless of how hard one might try to extract something.
One noteworthy consideration is a possible effect of the homozygous form on BH4 (tetrahydrobiopterin), a cofactor in serotonin, dopamine, and nitric oxide synthesis. This exploration is the least-cited part of the reliable record - a mechanistic possibility rather than an established, replicated result. Varia will continue to monitor the landscape as science develops.
What Varia does with this variant
Varia reads rs1801131 directly from your raw DNA file and resolves your genotype locally on your own device. The result appears under Metabolism and Longevity, in the Methylation and Detoxification module, with the matching catalog summary and the linked, peer-reviewed citations above. Because A1298C is most meaningful next to C677T, the Varia Genome Scanner reads rs1801133 alongside it and reports the compound pattern when both are present. We describe what the published evidence reports. We do not tell you what to take or do, and we do not carry a claim the catalog cannot cite. Our intention is to hand you the facts as they stand, without sugarcoating and without fear-mongering.
Questions and answers
Is A1298C as significant as C677T?
Not on its own. The catalog ties A1298C much less tightly to elevated homocysteine than C677T, and its best-documented role is in the compound pattern, one A1298C allele alongside one C677T allele PMID 9545395. Read in isolation, a single A1298C result carries less weight than a C677T result.
What is compound heterozygosity?
It means carrying one copy of A1298C (rs1801131) and one copy of C677T (rs1801133) at the same time. Varia's catalog flags this combination as the configuration where A1298C becomes most interpretively relevant, which is why the Varia Genome Scanner reads both positions before describing either.
Does A1298C mean something is wrong with me?
No. The variant is common, tens of thousands of people carry two copies, and its measured effect on its own is small. It describes a tendency studied across groups, not a diagnosis for an individual.
The short version
What is established: A1298C is a common, distinct MTHFR variant, separate from C677T, and on its own it is tied only weakly to the homocysteine and folate pathway the gene sits in PMID 20814827.
What is not established: any independent, significant disease effect for A1298C alone. The one disease-association figure here, for the compound pattern with C677T, crossed the line into no-effect territory PMID 9545395, and the BH4 mechanism the entry mentions is a possibility, not a proven, repeated result.
To check your own genotype, see whether you carry the compound pattern with C677T, and read the cited, peer-reviewed evidence behind each call, use the Varia Genome Scanner. It reads your raw DNA file in your browser and checks it for rs1801131 along with the rest of the catalog. Array files like 23andMe and AncestryDNA cover most catalog variants but not all, so the scan tells you whether yours is included, and your file never leaves your device.